MIN; Xiaoshan

Patent Applications and Registrations

Patent applications and USPTO patent grants for MIN; Xiaoshan.The latest application filed is for "st2 antigen binding proteins".

Company Profile

10.10.16

MIN; Xiaoshan - Burlingame CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
St2 Antigen Binding Proteins App 20220119537 - SMITH; Dirk E. ; et al.	2022-04-21
Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (gipr) In Combination With Glp-1 Agonists App 20220025059 - YIE; Junming ; et al.	2022-01-27
Tigit And Cd112r Blockade App 20220017616 - SOHN; Sue J. ; et al.	2022-01-20
ST2 antigen binding proteins Grant 11,059,895 - Smith , et al. July 13, 2	2021-07-13
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists Grant 11,046,774 - Yie , et al. June 29, 2	2021-06-29
Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (gipr) In Combination With Glp-1 Agonists App 20210087286 - BATES; Darren L. ; et al.	2021-03-25
Growth Differentiation Factor 15 (gdf-15) Constructs App 20210079051 - XIONG; Yumei ; et al.	2021-03-18
Growth differentiation factor 15 (GDF-15) constructs Grant 10,894,814 - Xiong , et al. January 19, 2	2021-01-19
St2 Antigen Binding Proteins App 20190359720 - SMITH; Dirk E. ; et al.	2019-11-28
Growth Differentiation Factor 15 (GDF-15) Polypeptides App 20190315822 - XIONG; Yumei ; et al.	2019-10-17
Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (gipr) In App 20190276546 - Yie; Junming ; et al.	2019-09-12
Growth differentiation factor 15 (GDF-15) polypeptides Grant 10,336,798 - Xiong , et al.	2019-07-02
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists Grant 10,294,303 - Yie , et al.	2019-05-21
ST2 antigen binding proteins Grant 10,227,414 - Smith , et al.	2019-03-12
ST2 antigen binding proteins Grant 9,982,054 - Smith , et al. May 29, 2	2018-05-29
Growth Differentiation Factor 15 (gdf-15) Constructs App 20180079790 - XIONG; Yumei ; et al.	2018-03-22
Growth differentiation factor 15 (GDF-15) constructs Grant 9,862,752 - Xiong , et al. January 9, 2	2018-01-09
Growth Differentiation Factor 15 (GDF-15) Polypeptides App 20170291929 - XIONG; Yumei ; et al.	2017-10-12
Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (gipr) In Combination With Glp-1 Agonists App 20170275370 - YIE; Junming ; et al.	2017-09-28
St2 Antigen Binding Proteins App 20170267769 - SMITH; Dirk E. ; et al.	2017-09-21
Growth differentiation factor 15 (GDF-15) polypeptides Grant 9,714,276 - Xiong , et al. July 25, 2	2017-07-25
St2 Antigen Binding Proteins App 20170002079 - SMITH; Dirk E. ; et al.	2017-01-05
ST2 antigen binding proteins Grant 9,382,318 - Smith , et al. July 5, 2	2016-07-05
Growth Differentiation Factor 15 (gdf-15) Constructs App 20160168213 - XIONG; Yumei ; et al.	2016-06-16
Growth Differentiation Factor 15 (gdf-15) Polypeptides App 20140378665 - Xiong; Yumei ; et al.	2014-12-25
St2 Antigen Binding Proteins App 20140004107 - SMITH; Dirk E. ; et al.	2014-01-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.